SCHEMBL6550048

SCHEMBL6550048

O=Cc1ccc(OCCCCCOc2c(Cl)cc(OCC=C(Cl)Cl)cc2Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.40
ALB P02768 1/20 0.36
CYP1A2 P05177 1/20 0.34
KDM4E B2RXH2 2/20 0.34
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PPARA Q07869 2/20 0.33
RAB9A P51151 1/20 0.33
FFAR1 O14842 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
CYSLTR2 Q9NS75 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6547674 0.99 ALDH1A1 (0.42) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL5605592 0.96 ALDH1A1 (0.45) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL6550042 0.95 HTT (0.42) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL6548265 0.88 HPGD (0.36) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL6548477 0.87 HPGD (0.37) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL8405697 0.86 HTT (0.42) ALDH1A1HTTKMT2ACYSLTR2MEN1
SCHEMBL6548549 0.86 MAOA (0.41) MAPTHPGDSMN1; SMN2HTTCYP1A2
SCHEMBL6548420 0.86 MEN1 (0.46) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL6548058 0.86 MEN1 (0.46) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL6547928 0.85 ALDH1A1 (0.35) ALDH1A1MAPTHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975586-B1 OXIME COMPOUNDS, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL CO (JP) 2004-12-01 EP disclosed
US-6448444-B2 INSECTICIDES, MITICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-09-10 US disclosed
US-6437184-B1 INSECTICIDES, ACARICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-08-20 US disclosed
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production SUMITOMO CHEMICAL COMPANY, LIMITED 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production CBR3, CBR1, NOX3 ALDH1A1 513/4885MAPT 4623/4885HPGD 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.